FibroGen
FGEN
$1.17
Share price
12.46%
Change (1 day)
-93.17%
Change (1 year)
Categories
FibroGen (FGEN) - Cash on Hand
Cash on Hand as of December 2023 : $0.23 B
According to FibroGen's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
FibroGen - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | -44.17% |
| 2022-12-31 | $0.42 B | 4.15% |
| 2021-12-31 | $0.40 B | -40.98% |
| 2020-12-31 | $0.68 B | 28.62% |
| 2019-12-31 | $0.53 B | -14.1% |
| 2018-12-31 | $0.62 B | -15.54% |
| 2017-12-31 | $0.73 B | 190.59% |
| 2016-12-31 | $0.25 B | 39.75% |
| 2015-12-31 | $0.18 B | 0.75% |
| 2014-12-31 | $0.17 B | 46.42% |
| 2013-12-31 | $0.12 B | 207.88% |
| 2012-12-31 | $39.88 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $1.05 B | 347.40% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | $13.21 M | -94.39% | 🇺🇸 USA |